The Chandran Lab
  • home
  • news & media
  • research
  • team
  • publications
  • find us
  • positions
The Chandran Lab
  • home/
  • news & media/
  • research/
  • team/
  • publications/
  • find us/
  • positions/
endocytic trafficking sketch_09_no UVRAG_Arl8b.001.png
The Chandran Lab

research

The Chandran Lab
  • home/
  • news & media/
  • research/
  • team/
  • publications/
  • find us/
  • positions/

 

Start typing to search for blog entry:

 
 
 

May 18, 2017

Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of Vulnerability→

May 18, 2017/ Kartik Chandran
Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of Vulnerability

Zhao X et al, Cell 2017

Read More
May 18, 2017/ Kartik Chandran/ Comment /Source
Ebola virus, filovirus, host factors, receptors, NPC1, researchpage, 2017
May 18, 2017

Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses→

May 18, 2017/ Kartik Chandran
Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses

Wec AZ et al, Cell 2017

Read More
May 18, 2017/ Kartik Chandran/ Comment /Source
Ebola virus, filovirus, host factors, receptors, NPC1, researchpage, 2017
September 08, 2016

A “Trojan horse” bispecific antibody strategy for broad protection against ebolaviruses→

September 08, 2016/ Kartik Chandran
A “Trojan horse” bispecific antibody strategy for broad protection against ebolaviruses

Wec AZ et al, Science 2016

Read More
September 08, 2016/ Kartik Chandran/ Comment /Source
2016-2017, Ebola virus, filovirus, therapeutics, antibody, host factors, NPC1, antivirals, researchpage, 2016
March 30, 2016

A Single Residue in Ebola Virus Receptor NPC1 Influences Cellular Host Range in Reptiles→

March 30, 2016/ Kartik Chandran
A Single Residue in Ebola Virus Receptor NPC1 Influences Cellular Host Range in Reptiles

Ndungo E et al, mSphere 2016

Read More
March 30, 2016/ Kartik Chandran/ Comment /Source
2016, Ebola virus, filovirus, host factors, receptors, NPC1, researchpage
February 23, 2016

Host-primed Ebola virus GP exposes a hydrophobic NPC1 receptor-binding pocket, revealing a target for broadly neutralizing antibodies→

February 23, 2016/ Kartik Chandran
Host-primed Ebola virus GP exposes a hydrophobic NPC1 receptor-binding pocket, revealing a target for broadly neutralizing antibodies

Bornholdt ZA et al, mBio 2016

Read More
February 23, 2016/ Kartik Chandran/ Comment /Source
Ebola virus, filovirus, NPC1, host factors, receptors, antibody, 2016-2017, researchpage, 2016
February 09, 2016

Direct Visualization of Ebola Virus Fusion Triggering in the Endocytic Pathway→

February 09, 2016/ Kartik Chandran
Direct Visualization of Ebola Virus Fusion Triggering in the Endocytic Pathway

Spence JS et al, mBio 2016

Read More
February 09, 2016/ Kartik Chandran/ Comment /Source
2016-2017, Ebola virus, membrane fusion, GP, filovirus, host factors, researchpage, 2016
January 29, 2016

Bispecific Antibody Affords Complete Post-Exposure Protection of Mice from Both Ebola (Zaire) and Sudan Viruses→

January 29, 2016/ Kartik Chandran
Bispecific Antibody Affords Complete Post-Exposure Protection of Mice from Both Ebola (Zaire) and Sudan Viruses

Frei JC, Nyakatura EK, et al, Sci Rep 2016

Read More
January 29, 2016/ Kartik Chandran/ Comment /Source
2016-2017, GP, antibody, therapeutics, Ebola virus, filovirus, 2016
January 20, 2016

Cysteine cathepsin inhibitors as anti-Ebola agents→

January 20, 2016/ Kartik Chandran
Cysteine cathepsin inhibitors as anti-Ebola agents

van der Linden W et al, ACS Infect Dis 2016

Read More
January 20, 2016/ Kartik Chandran/ Comment /Source
2016-2017, cathepsin, filovirus, antivirals, Ebola virus, researchpage, 2016
December 23, 2015

Filovirus receptor NPC1 contributes to species-specific patterns of ebolavirus susceptibility in bats→

December 23, 2015/ Kartik Chandran
Filovirus receptor NPC1 contributes to species-specific patterns of ebolavirus susceptibility in bats

Ng M, Ndungo E, Kaczmarek ME et al, eLife 2015

Read More
December 23, 2015/ Kartik Chandran/ Comment /Source
Ebola virus, filovirus, host factors, receptors, NPC1, researchpage, 2014–2015, 2015
July 22, 2015

Novel small molecule entry inhibitors of Ebola virus→

July 22, 2015/ Kartik Chandran
Novel small molecule entry inhibitors of Ebola virus

Basu A et al, J Infect Dis 2015

Read More
July 22, 2015/ Kartik Chandran/ Comment /Source
Ebola virus, therapeutics, filovirus, GP, 2014–2015, antivirals, 2015
May 26, 2015

Niemann-Pick C1 Is essential for ebolavirus replication and pathogenesis in vivo→

May 26, 2015/ Kartik Chandran
Niemann-Pick C1 Is essential for ebolavirus replication and pathogenesis in vivo

Herbert AS et al, MBio 2015

Read More
May 26, 2015/ Kartik Chandran/ Comment /Source
Ebola virus, filovirus, NPC1, pathogenesis, host, animal model, receptors, host factors, therapeutics, 2014–2015, antivirals, researchpage, 2015
October 11, 2014

Cell entry by a novel European filovirus requires host endosomal cysteine proteases and Niemann-Pick C1→

October 11, 2014/ Kartik Chandran
Cell entry by a novel European filovirus requires host endosomal cysteine proteases and Niemann-Pick C1

Ng M et al, Virology 2014

Read More
October 11, 2014/ Kartik Chandran/ Comment /Source
Ebola virus, Lloviu virus, NPC1, host factors, 2014–2015, filovirus, receptors, researchpage, 2014
August 20, 2014

Synthetic antibodies with a human framework that protect mice from lethal Sudan ebolavirus challenge→

August 20, 2014/ Kartik Chandran
Synthetic antibodies with a human framework that protect mice from lethal Sudan ebolavirus challenge

Chen G, Koellhoffer JF, Zak SE et al, ACS Chem Biol 2014

Read More
August 20, 2014/ Kartik Chandran/ Comment /Source
therapeutics, antibody, GP, pathogenesis, animal model, 2014–2015, filovirus, 2014
January 28, 2014

Comprehensive functional analysis of N-linked glycans on Ebola virus GP1→

January 28, 2014/ Kartik Chandran
Comprehensive functional analysis of N-linked glycans on Ebola virus GP1

Lennemann NJ et al, MBio 2014

Read More
January 28, 2014/ Kartik Chandran/ Comment /Source
GP, vaccine, 2014–2015, filovirus, 2014
August 02, 2013

C-Peptide inhibitors of Ebola virus glycoprotein-mediated cell entry: Effects of conjugation to cholesterol and side chain-side chain cross linking→

August 02, 2013/ Kartik Chandran
C-Peptide inhibitors of Ebola virus glycoprotein-mediated cell entry: Effects of conjugation to cholesterol and side chain-side chain cross linking

Higgins CD et al, Bioorg Med Chem Lett 2013

Read More
August 02, 2013/ Kartik Chandran/ Comment /Source
filovirus, membrane fusion, antivirals
April 19, 2013

Conformational properties of peptides corresponding to the ebolavirus GP2 membrane-proximal external region in the presence of micelle-forming surfactants and lipids→

April 19, 2013/ Kartik Chandran
Conformational properties of peptides corresponding to the ebolavirus GP2 membrane-proximal external region in the presence of micelle-forming surfactants and lipids

Regula LK, Harris R et al, Biochemistry 2013

Read More
April 19, 2013/ Kartik Chandran/ Comment /Source
Ebola virus, filovirus, membrane fusion, GP, 2012–2013, antivirals, 2013
January 09, 2013

A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species and cell-type specific manner→

January 09, 2013/ Kartik Chandran
A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species and cell-type specific manner

Martinez O et al, J Virol 2013

Read More
January 09, 2013/ Kartik Chandran/ Comment /Source
2012–2013, filovirus, NPC1, host factors, receptors, 2013
December 11, 2012

Endocytic pathways involved in filovirus entry: advances, implications and future directions→

December 11, 2012/ Kartik Chandran
Endocytic pathways involved in filovirus entry: advances, implications and future directions

Bhattacharyya S et al, Viruses 2012

Read More
December 11, 2012/ Kartik Chandran/ Comment /Source
2012–2013, filovirus, host factors, receptors, review, 2012
October 30, 2012

Two synthetic antibodies that recognize and neutralize distinct proteolytic forms of the Ebola virus envelope glycoprotein→

October 30, 2012/ Kartik Chandran
Two synthetic antibodies that recognize and neutralize distinct proteolytic forms of the Ebola virus envelope glycoprotein

Koellhoffer JF, Chen G et al, Chembiochem 2012

Read More
October 30, 2012/ Kartik Chandran/ Comment /Source
Ebola virus, filovirus, antibody, 2012–2013, researchpage, 2012
October 25, 2012

NPC1/NPC1-like1 Chimeras Define Sequences Critical for NPC1’s Function as a Filovirus Entry Receptor→

October 25, 2012/ Kartik Chandran
NPC1/NPC1-like1 Chimeras Define Sequences Critical for NPC1’s Function as a Filovirus Entry Receptor

Krishnan A et al, Viruses 2012

Read More
October 25, 2012/ Kartik Chandran/ Comment /Source
2012–2013, receptors, NPC1, filovirus, Ebola virus, host factors, researchpage, 2012
  • Next

© 2015, Kartik Chandran Laboratory